Core Molding Technologies

Manufacturing Expansion And Advanced Composites Will Unlock New Markets

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

09 Feb 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

25.5%

9.2%

25.5%

9.2%

You can edit this narrative until May 12 6:01 AM. Then, changes will post as Updates.

Author's Valuation

US$227.0% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Increased 11%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Decreased 5.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Decreased 4.41%

AnalystConsensusTarget has decreased revenue growth from -7.0% to 0.9% and decreased future PE multiple from 15.0x to 11.8x.

AnalystConsensusTarget Fair Value

US$22

7.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.45%

Chemicals revenue growth rate

0.62%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.59%

Calculation

US$22.38m

Earnings '28

9.78x

PE Ratio '28

US$218.88m

Market Cap '28

US$218.88m

Market Cap '28

8.30m

No. shares '28

US$26.37

Share Price '28

US$26.37 Share Price '28

Discounted to 2025 @ 7.54% p.a.

US$21.21

Fair Value '25